From the Global Fund: COVID-19 Situation Report 9 October 2020 The Global Fund Secretariat has provided an update on the use of funds made available to support the COVID-19 response. It has so far approved the disbursement of $806 million, mainly through the COVID-19 Response Mechanism (C19RM), to 106 countries and 12 multi-country programs. The report also detailed the devastating effects of…
In a virtual meeting convened by the African Union on 8 and 9 October 2020, health and finance ministers from east and southern Africa discussed how to sustain Africa’s earlier health gains in the face of COVID-19. They agreed on the dual importance of raising domestic resources for health and improving the management of available resources. The stance is summarized…
COVID-19, weak political commitment, and low domestic investments in health are significant barriers in the fight against human immunodeficiency virus (HIV), tuberculosis (TB), and malaria in Latin America and the Caribbean (LAC) region. The LAC countries are also grappling with transitioning away from Global Fund support amid profound socioeconomic inequalities, barely sustainable civil society programming, and poor universal health coverage…
As countries finalize their funding requests to the Global Fund or negotiate their grants for the 2020-2022 allocation cycle, it becomes important to reflect on systemic issues reported in the previous allocation cycle. Our review of the Office of the Inspector General (OIG) audit reports for 2019-2020 reveals that inaccurate and incomplete data is the third leading issue plaguing Global…
Over the past ten years, more Program Management Units (PMUs) have been established within Ministries of Health to attract funding from international donors. They receive funds, select implementing partners, establish monitoring and reporting frameworks aligned to donor requirements, and ensure transparency on external funding. PMUs are responsible for managing projects financed by large vertical funds such as the Global Fund…
The role of national central procurement agencies National central procurement agencies for essential drugs fulfill a public service with a social purpose, in accordance with their national pharmaceutical policies. Those institutions, called CAMEG (La Centrale d’Achat des Médicaments Essentiels Génériques et des consommables médicaux) for Central Agencies for Essential and Generic Medicines, are autonomous government institutions that purchase quality medications, laboratory reagents…
Please help us do this by filling out this online survey https://www.surveymonkey.com/r/6D6QZ79 by 28 October 2020. All responses will remain anonymous and confidential.
Subscribe to our newsletter below and never miss the latest updates.
Subscribe to our weekly newsletter below.
